FinDogFinDog
Friday, October 30, 2026Closing data · 4:00 PM ET
English
Log in

RVTY

RevvityNYSE · Health Care Equipment · Health Care
Previous close
157.00
Change
−8.78 / −5.30%
FinDog View
Bullish
52-Week Range ?
81.22 – 169.06
P/E (TTM) ?
73.7
Forward P/E ?
25.0
Based on consensus earnings for the next 12 months
Market Cap
$17.4B
1M
+2.69%
S&P 500 −0.91% over same period
Volume / Avg Volume
3.2M / 1.5M
2.06× average
Latest earnings analysisFY2026 Q2Reported 2026-08-04

Revvity Q2 FY2026: $729.7 million revenue, guidance raised

Revvity's fiscal 2026 second quarter was a modest top line with a strong bottom line: revenue of $729.7 million grew 1.3% reported and 4.0% pro forma, and adjusted EPS of $1.41 beat the $1.2468 consensus by 13.1%, helped by $0.11 of tariff refunds. Read the Diagnostics-driven mix shift and the small guidance raise as the real story.

Read the full analysis →
Revenue$0.73BYoY +1.30%
EPS (non-GAAP)$1.41Beatest. $1.25
Next-quarter revenue guidance$2.85BYoY +289.90%
Next-day move+3.26%

Price History

Closing price · USD1M6M1Y5Y
80100120140160180EFY26 Q2 EarningsEFY26 Q1 Earnings2026-042026-062026-082026-092026-10

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 54.71M6M1Y5Y
40506070802026-042026-062026-082026-092026-10

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis

Next Earnings

Date and consensus from the earnings calendar; the analysis is generated automatically after the releaseEarnings Calendar →
Report date
2026-11-03
in 2 days · Pre-market
Consensus EPS
$1.33
Last quarter EPS $1.41
Avg. next-day move over the last 6 reports
±2.4%

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 83 of its 5-year rangeExpensive
5-year range 16.4 – 87.2 · Median 46.9
Last 4 quarters: $476M in buybacks + $31.7M in dividends, 2.91% of market cap combined
P/E (TTM)
73.7
P/B
2.4
P/S
6.0
Dividend Yield
0.31%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.4% on average on the first trading day after, rising 4 times
Most recent +3.26%
Volatility & Correlation
1-year beta 0.80 · Correlation with S&P 500 0.25Tracks the market
Annualized volatility 39% vs. 12% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 3 · $1.3MNet selling $1.3M
  • 10-01Gonzales AnitaVP and CAOSell$0.01M84 shares · Avg price 155.48
  • 09-21Krakowiak MaxwellPlease See RemarksSell$0.24M1,631 shares · Avg price 144.53
  • 09-16Vohra Tajinder SPlease See RemarksSell$1.0M7,330 shares · Avg price 140.88
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q20.73+1.3%57.1%0.090.050.180.47
FY2026 Q10.71+7.0%54.5%0.080.040.100.36
FY2025 Q40.77+5.9%—0.110.100.160.86
FY2025 Q30.70+2.2%53.6%0.080.050.120.40
FY2025 Q20.72+4.1%54.5%0.090.050.120.46
FY2025 Q10.66+2.3%56.5%0.070.040.110.35
FY2024 Q40.73+4.8%—0.120.090.150.77
FY2024 Q30.68+2.0%56.3%0.100.090.130.77
FY2024 Q20.69−2.5%55.7%0.090.060.140.45
FY2024 Q10.65−3.7%54.6%0.040.030.130.21
FY2023 Q40.70−6.1%—0.080.080.170.69
FY2023 Q30.67−5.8%55.5%0.070.01-0.060.08

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView